Anthrogenesis, based in Cedar Knolls, New Jersey, is a biotherapeutics company that has developed proprietary methods for collecting, processing and storing stem cells and other valuable biomaterials derived from human placental tissue. Anthrogenesis is focused on developing and delivering therapies using stem cells sourced from human placental tissue to treat cancers and immunological, metabolic and inflammatory diseases. Anthrogenesis has demonstrated that the human placenta is an abundant source of biotherapies, including early stage stem cells and other biomaterials for organ and tissue repair. Anthrogenesis also operates Lifebank, a state-licensed blood bank that banks stem cell transplant units derived from placental tissue and in some cases, blood from the umbilical cord that is collected immediately after birth.

Celularity, Inc. a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert J. Hariri in 2016 and is headquartered in Florham Park, NJ.

RBio is superior pharmaceutical production standards (GMP) in the appropriate cell therapy manufacturing facilities were seolrim derived from adipose tissue for stem cell therapy in the world No.1 in technology of rare, incurable diseases and other treatment difficult disease for clinical trials and progress and We are devoting ourselves to commercializing therapeutics.

HLI Cellular Therapeutics LLC provides therapeutics services. The company is headquartered in San Diego, CA.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Guangdong General Hospital (Chinese: 广东省人民医院 meaning "Guangdong Provincial People's Hospital") is a large hospital, founded in 1946, located in Yuexiu District, Guangzhou, Guangdong, China.

Guangdong Cardiovascular Institute is a private company headquartered in Guangdong, China, that provides healthcare and surgical services.

Primoris Therapeutics Co., Ltd. is a company headquartered in the South Korea that develops biopharmaceuticals.

Hubei Life Source Stem Cell Co., Ltd., established on 2010-05-19, The scope of business includes cell culture and the provision of related technical services;stem cell,Component blood,Cancer prevention and related biomedical technology research and technical services;Stem Cell Products Research,to develop,Technical consultation and achievement transformation;Autologous stem cell preservation and provision of related technical services;Information consultation on autologous stem cell preservation agency,technical consulting;own property for rent;R&D of cosmetics,Production,Wholesale and retail;Research and development of Class Ι medical devices,Production,Technical Services,Wholesale and retail;laboratory reagent(Does not contain dangerous goods)and consumables,Wholesale and retail of instruments and meters.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Since the company’s founding, Cord Blood Registry® (CBR®) has led the industry in technical innovations and provided families with access to current treatments and experimental stem cell therapies for conditions that have no cure. Cord Blood Registry (CBR) is the world’s largest newborn stem cell company. Founded in 1992, CBR is entrusted by parents with storing samples from more than 500,000 children. CBR is dedicated to advancing the clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today. CBR has helped more than 300 families use their cord blood stem cells for established and experimental medical treatments, more than any other family cord blood bank. CBR’s goal is to expand the potential scope of newborn stem cell therapies that may be available to patients and their families. Cord Blood Registry is headquartered in San Bruno, California. CBR’s owned 80,000 square foot laboratory is located in Tucson, Arizona. Cord Blood Registry is a registered trademark of CBR Systems, Inc. CBR maintains standards for cellular therapy services through AABB accreditation, FDA-registration, and CLIA certification. CBR has the longest history of accreditation with the AABB (formerly known as the American Association of Blood Banks) and the company’s quality standards have been recognized through ISO 9001:2008 certification — the global business standard for quality. A pioneer in newborn stem cell collection and cryopreservation, CBR believes in the power of newborn stem cells to improve lives today and their potential to revolutionize treatment for many conditions in the future. CBR is the first family newborn stem cell bank to partner with leading research institutions to establish FDA-regulated clinical trials exploring the potential regenerative ability of stem cells to help treat conditions that have no cure today, including: acquired hearing loss, autism, cerebral palsy, and pediatric stroke. In fact, 73% of the stem cell units released by CBR have been used for experimental regenerative therapies – more than any other family cord blood bank in the world.

Anhui Gaoan Biomedical Technology Co., Ltd., established on 2017-06-13, Business scope includes engaging in research and development of medical science and technology,Technical Services,Research and development of human immune cells and stem cells,Sales and stem cell storage business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Provides research and development on medical sciences and pharmacy

Beizheng Sail (Beijing) Biotechnology Co., Ltd., established on 2014-11-15, Business scope includes technology development,technology transfer,technical consulting,Technical Services;sell electronics,medical deviceIkind,cosmetic,hygiene products,Chemical Products(Free of Hazardous Chemicals);Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Natural science research and experimental development;sell food;wholesale medicine;medical service;Sales of Class III Medical Devices.(Enterprises independently choose operating projects according to law,Carry out business activities;medical service,sell food,wholesale medicine,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Yunnan New Life Stem Cell Co., Ltd., established on 2009-12-28, Business scope includes stem cell storage technology services;stem cell collection,detection,to prepare,Freezing and Serving;stem cell,Component blood,cosmetic,cosmetic,immune cell technology,Research on Medical Testing Technology,to develop,technical consulting,technology transfer,Technical Services,Achievement transfer;Diagnosis and treatment technology development;cosmetic,laboratory reagent,Diagnostic reagents(Hazardous chemicals excluded),R&D of medical devices,production and sales;Genetic testing and genetic data analysis services;Own house rental(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Hydrojoule LLC is a private company headquartered in the United States that provides consulting services in machine learning, business development, SaaS, PaaS, funding and architecture.

CAR-T (Shanghai) Biotech Co., Ltd. engages in the research and development bioengineering, medical, stem cells, and healthcare services. Its business scope includes manufacture of medical devices, hygiene supplies, and disposable medical supplies; and technical development, services, consulting, and technology transfer of therapeutic technology, biotechnology, laboratory equipment technology, and cosmetics technology. The company was founded on December 31, 2015 and is headquartered in Shanghai, China.

Shandong Qilu Stem Cells Engineering Co. Ltd. operates a cord blood bank. The firm offers stem cell clinical research and technology development, and umbilical cord blood stem cell preservation services. The company was founded in July 2004 and is headquartered in Jinan, China.

Dongying Fengqi Biotechnology Development Co., Ltd., established on 2013-01-05, Business scope includes biological and biological product technology research,technology development,Technical Services,technology transfer;cosmetic,Ι class medical device,Instrument sales;Biological reagent research and development,Sales(Does not contain dangerous goods);Development and Application of Stem Cell Technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shandong Xinchao Biotechnology Co., Ltd., established on 2018-12-10, Business scope includes general items:Research and development of bio-based materials technology;Medical Research and Experimental Development;R&D and application of cell technology;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Cosmetics Retail;Cosmetics Wholesale;internet sales(Except for products that require a license for sale);Experimental analysis instrument sales;Instrument sales;Retailing of computer software, hardware and auxiliary equipment;Specialty Chemicals Sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products);Cloud Computing Equipment Technical Services;software development;software sales;Information system integration service;Information Technology Consulting Services;Data processing and storage support services;Technology Import and Export;Import and export;Business Management Consulting;Conference and Exhibition Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business;Drug retail;Cosmetic production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)